BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

51 related articles for article (PubMed ID: 17433911)

  • 1. Differentiation therapy of leukemia: 3 decades of development.
    Nowak D; Stewart D; Koeffler HP
    Blood; 2009 Apr; 113(16):3655-65. PubMed ID: 19221035
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Differentiation syndrome in acute promyelocytic leukemia: A leopard cannot change its spots.
    Schiavini G; Blum S; Tsilimidos G
    Int J Lab Hematol; 2024 May; ():. PubMed ID: 38711240
    [No Abstract]   [Full Text] [Related]  

  • 3. High-affinity neurotrophin receptors and ligands promote leukemogenesis.
    Li Z; Beutel G; Rhein M; Meyer J; Koenecke C; Neumann T; Yang M; Krauter J; von Neuhoff N; Heuser M; Diedrich H; Göhring G; Wilkens L; Schlegelberger B; Ganser A; Baum C
    Blood; 2009 Feb; 113(9):2028-37. PubMed ID: 19059881
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Sorafenib induces apoptosis specifically in cells expressing BCR/ABL by inhibiting its kinase activity to activate the intrinsic mitochondrial pathway.
    Kurosu T; Ohki M; Wu N; Kagechika H; Miura O
    Cancer Res; 2009 May; 69(9):3927-36. PubMed ID: 19366808
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Detection of BCR-ABL gene mutations in Philadelphia chromosome positive leukemia patients resistant to STI-571 cancer therapy.
    Chien JH; Tang JL; Chen RL; Li CC; Lee CP
    Leuk Res; 2008 Nov; 32(11):1724-34. PubMed ID: 18603297
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mutant transcription factors and tyrosine kinases as therapeutic targets for leukemias: from acute promyelocytic leukemia to chronic myeloid leukemia and beyond.
    Hu J; Zhou GB; Wang ZY; Chen SJ; Chen Z
    Adv Cancer Res; 2007; 98():191-220. PubMed ID: 17433911
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Molecular targets and the treatment of myeloid leukemia.
    Ikeda A; Shankar DB; Watanabe M; Tamanoi F; Moore TB; Sakamoto KM
    Mol Genet Metab; 2006 Jul; 88(3):216-24. PubMed ID: 16678459
    [TBL] [Abstract][Full Text] [Related]  

  • 8. From dissection of disease pathogenesis to elucidation of mechanisms of targeted therapies: leukemia research in the genomic era.
    Zhou GB; Li G; Chen SJ; Chen Z
    Acta Pharmacol Sin; 2007 Sep; 28(9):1434-49. PubMed ID: 17723177
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Retinoic acid receptors, hematopoiesis and leukemogenesis.
    Collins SJ
    Curr Opin Hematol; 2008 Jul; 15(4):346-51. PubMed ID: 18536573
    [TBL] [Abstract][Full Text] [Related]  

  • 10.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 11.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 12.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 13.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 14.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 15.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 16.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 17.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 18.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 3.